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Abstract
The development of a ring-opening metathesis/ring-closing metathesis/cross metathesis (ROM-
RCM-CM) cascade strategy to the synthesis of a diverse collection of bi- and tricyclic sultams is
reported. In this study, functionalized sultam scaffolds derived from intramolecular Diels-Alder
(IMDA) reactions undergo metathesis cascades to yield a collection tricyclic sultams. Additional
appendage based diversity was achieved by utilizing a variety of CM partners.
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1. Introduction
Diversity-oriented-synthesis (DOS) has emerged as a powerful strategy in the generation of
structurally complex and skeletally diverse small molecules.i Collections of such small
molecules can possess a wide range of physical and biological properties and as such are ideal
for probing chemical space to identify novel lead compounds.ii The development of simple
methodology, which allows for the generation of skeletal diversity is one of the most
challenging facets of DOS. A number of efficient strategies have emerged employing skeletal
rearrangement utilizing both functional-group-pairing (FGP)iii strategies and tandem
metathesis (TM) strategies.iv In this regard, we envisioned an approach whereby skeletally
diverse sultam scaffolds could be generated using a domino ring-opening metathesis (ROM)/
ring-closing metathesis (RCM)/cross metathesis (CM) cascade sequence on a readily derived
oxa-norbornenyl sultam. Recently a number of strategies employing ROM-CM strategies of
norbornenes, oxa-norbornenes and aza-norbornenes derivatives have appeared.v In particular,
a number of key metathesis cascades and strategies have emerged, some in the context of
DOS.vi Herein is reported the application of a ROM-RCM-CM strategy for the generation of
a collection of skeletally diverse sultams starting from a central norbornenyl sultam core
derived from a diastereoselective intramolecular Diels-Alder (IMDA) reaction (Scheme 1).
Correspondence to: Paul R. Hanson.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Tetrahedron. Author manuscript; available in PMC 2010 June 27.
Published in final edited form as:













Sultams (cyclic sulfonamide analogs) have emerged as important targets in drug discovery due
to their potent biological activities. A number of reports have highlighted an assortment of
sultams that display potent activity including inhibition of COX-2 (Ampiroxicam),vii,viii HIV
integrase,ix and cysteine protease involved in the progression of maleria.x Recently, a number
of transition metal-catalyzed approaches to sultams have come to light, including ring-closing
metathesis (RCM).xi Our continued interest in the development of new synthetic routes towards
structurally diverse sulfur-containing small moleculesxii for library production has prompted
the following investigation on the application of metathesis cascade processes for their
construction.
2. Results and discussion
The intramolecular Diels-Alder (IMDA) reaction of both vinyl sulfonatesxiii and vinyl
sulfonamidesxiv with substituted furans, pioneered by Metz and coworkers, have provided an
efficient route to highly versatile intermediates rich in stereochemistry and functionality.
Norbornene systems of this type, possess a strained internal double bond, and thus are attractive
scaffolds for application of the aforementioned metathesis cascades. To this effect, we set about
the synthesis of IMDA derived sultams 1 and 2 from commercially available starting
materials.xiv c 2-Chloroethanesulfonyl chloride was coupled with furfuryl amine to afford the
corresponding sulfonamide in 86 % yield. Alkylation of the resulting sulfonamide followed
by in-situ IMDA afforded the corresponding tricyclic sultams 1 and 2 in 55% and 58% yield,
respectively (Scheme 2), as single diastereomers.
With scaffold 1 in hand, the application of the proposed ROM-RCM-CM cascade protocol was
explored. Thus, sultam 1 was subjected to 5 mol% of (IMesH2)(PCy3)(Cl)2Ru=CHPh [cat-
B],xv at 0.005 M in CH2Cl2 at 45 °C under argon for 3 hours, to afford homodimer 3 in 84%
yield. In order to circumvent this homodimerization pathway, a cross metathesis partner was
used to yield the desired product. Utilization of ethylene has been well reported in the
application of ROM-RCM-CM, whereby a terminal olefin is ultimately produced.vi With this
in mind, sultam 1 was submitted to standard cascade conditions under an atmosphere of
ethylene, in ethylene degassed solvent. As anticipated, the corresponding sultam 4 bearing a
terminal olefin was afforded in 74% yield with ethylene acting as the final cross-metathesis
partner. Building on this result, studies were directed toward the addition of a cross-metathesis
partner to prevent dimerization and incorporate an additional point of diversity.v When 1 was
resubjected in the presence of 10 equivalents of ethyl acrylate, 10 mol% of cat-B in 0.005 M
CH2Cl2 at 50 °C, the desired bridged tricyclic sultam 5 derived from ROM-RCM-CM was
isolated in 65% yield (Scheme 3).
With the successful application of a ROM-RCM-CM protocol, the scope of possible cross
metathesis partners was investigated. These included a variety of acrylates such as methyl
acrylate and t-butyl acrylate affording the desired products in good yield (Table 1, entrys 1–
3). Surprisingly, the application of methyl vinyl ketone (MVK) did not afford the desired
product. In addition to acrylates, styrene and acrylonitrile were utilized as the cross-metathesis
partner. It was found that under standard reaction conditions the desired products were isolated
as the sole product in good yields (Table 1, entrys 4–6).
With this result in hand, application of the metathesis cascade was applied to the propargyl-
substituted sultam 2. In this case, a ring-opening metathesis/ring-closing enyne metathesis/
cross-metathesis (ROM-RCEM-CM) sequence was envisioned as a means of generating
skeletal diversity. Moreover, reaction of sultam 2 in the presence of ethylene would afford the
desired product 11 bearing a diene motif, allowing for additional incorporation of diversity via
a [4+2] cycloaddition with activated dienophiles. However, when sultam 2 was submitted to
the ROM-RCEM-CM conditions none of the desired product was obtained, instead the
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corresponding bicyclic tetraene 12 was isolated in good yield (75%). This result indicates that
sultam 2 undergoes an intermolecular enyne metathesis with ethylene instead of the
corresponding intramolecular process. Subsequent heating of 12 with maleimide afforded the
corresponding [4+2] cis-cycloadduct 13 in 83% yield as an inseparable, 1:1 mixture of
diastereomers (Scheme 5).xvi
Building on these results, we investigated the synthesis of a modified sultam scaffold whereby
the simple relocation of the allyl group in 1 by one carbon would allow for the generation of
new tricyclic sultams 15–17 (Scheme 6). Relocation of the tethered allyl group also enhances
structural diversity by yielding a new fused ring system. Thus, 2-furaldehyde was condensed
with p-methoxy benzyl amine generating the corresponding imine, which was subsequently
converted to the requisite furfuryl-substituted allyl amine by the addition of allyl magnesium
bromide. Sulfonylation with 2-chloroethane sulfonyl chloride produced the corresponding
vinyl sulfonamide 14, which when heated at 100 °C for 12 h afforded the desired IMDA derived
scaffold 15 in 95% as a mixture of diastereomers (~1:1).xvii Addition of cat-B to sultam 15 in
the presence of ethylene afforded the desired tricyclic sultam 16 as a single diastereoisomer
via a ROM-RCM-CM cascade. Spectroscopic analysis including key 1H NMR nOe studies
determined that diastereomer 15a selectively underwent cyclization to give the cis-fused
tricyclic sultam 16.
In addition to the formation of 16, a small amount of sultam 17 resulting from ROM-CM of
diastereomer 15b with ethylene was isolated. It is proposed that in the case of diastereomer
15b, an unfavourable steric interaction between the homoallyl substituent and the oxo-bridge,
prevents proper alignment between the ruthenium alkylidene and the norbornenyl olefin, thus
hindering metathesis. However, this interaction is alleviated in the case of the diastereomer
15a, where the allyl group is oriented away from the oxygen bridge under the bicyclic ring in
direct proximity of the strained norbornenyl olefin (Scheme 7). In addition to steric effects, the
corresponding cyclized RCM product of 17 would have a trans ring junction in a bicyclo[3.3.0]
ring system which under the reversible conditions of the reaction would most likely be
disfavored.
During this investigation we were concurrently developing the synthesis of an IMDA-derived
sultam 21 bearing additional handles and therefore probed its utility in the metathesis cascade
protocol. In this regard, N-Boc phenylalanine was converted to the corresponding Weinreb
amide and treated with lithiated furan. Subsequent reduction of the furyl ketone yielded the
corresponding N-Boc amino alcohol 20 as a mixture of diastereoisomers (~2:1) in 64% yield
over 3 steps.xviii Removal of the Boc-group furnished the corresponding amino alcohol, which
was taken on crude to a one-pot, sulfonylation/diastereoselective IMDA sequence to afford the
desired tricyclic sultam 21, as a single diastereoisomer in 52% yield over three steps (Scheme
8).xiv
From a DOS perspective, sultam 21 represents an attractive scaffold due to a number of
features, including (i) the presence of both free hydroxy (OH) and free sulfonamide (NH)
groups, (ii) structural rigidity, (iii) stereochemistry and (iv) peripheral functionality. These
features allow for the generation of focused libraries to probe chemical space via two
approaches. One is via simple peripheral diversification and the second is via skeletal diversity
utilizing the aforementioned ROM-RCM-CM cascade protocol. To this effect, chemoselective
O-allylation of 21 yielded the desired intermediate 22,xix which when submitted to the standard
ROM-RCM-CM sequence yielded the desired tricyclic sultam 23 in 90% yield (Scheme 9).
Building on this result, selective acylation of 21 yielded the corresponding sultam intermediate
24 in 92% yield. Submission to the standard metathesis cascade conditions in the presence of
ethylene yielded the triene sultam 25 as the sole product via a ROM-CM process. Taken
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collectively, sultams 1, 15 and 21 are tricyclic, IMDA-derived scaffolds that upon submission
to the metathesis cascade protocol generate skeletally diverse [6.6.5] or [6.5.5] fused-ring
sultam systems. In addition, both pathways retain a functional handle (SO2NH) for late stage
peripheral diversification. Ultimately, selective choice of the olefin appendage in 21 allows
additional skeletal diversity in the formation of either tricyclic sultam 23 or bicyclic sultam
25, presumably due to variable olefin reactivity Types (I, II, II or IV) as defined by Grubbs
affecting the site of the initial metathesis event.xx
The synthesis of a sultam scaffold bearing an ester functional handle was envisioned as an
alternative strategy towards the synthesis of functionalized derivatives of 1. This goal could
be achieved via incorporation of the ester moiety in the dienophile component of the IMDA
protocol, as reported by Overman and coworkers.xxi To this effect, furfurylamine was
mesylated then subsequently allylated to yield sulfonamide 26 in 82% over 2 steps. Generation
of the phosphonate, followed by Horner-Wadsworth-Emmons reaction, yielded a mixture of
uncyclized sulfonamide 27 and IMDA-derived sultam 28 after purification to remove any
remaining starting material. Addition of hexane to the crude mixture resulted in the sole
precipitation of 28, yielding X-ray quality crystals (Scheme 10).
It is noteworthy to mention that it was observed that in both CDCl3 and d4-MeOD, sultam
28 undergoes retro-IMDA to the corresponding sultam 27 over time.xxii It is believed that the
nature of the solvent catalyzes the retro IMDA reaction indicating the increased reactivity of
the bridged tricyclic system in comparison to sultams 1 and 15. Despite this observation, the
corresponding sultam 28 underwent the metathesis cascade transformation in the presence of
ethylene in CH2Cl2 to yield the desired tricyclic sultam 29 (Scheme 11). Formation of an
additional lactone ring was achieved using iodolactonization between the ethyl ester and the
terminal olefin in the presence of I2 to afford polycyclic product 30 as a single isomer, albeit
in low yield.
Conclusion
In conclusion, the synthesis of a collection of diverse bi- and tricyclic sultams has been achieved
in an overall DOS approach utilizing a ROM-RCM-CM cascade strategy. A variety of
functionalized, tricyclic sultams were generated as precursors for the metathesis cascade
strategy. These precursors were derived from a diastereoselective IMDA reaction in good
yields and selectivity. The ROM-RCM-CM proceeded in good to excellent yields generating
sultams possessing both skeletal and appendage-based diversity that was controlled by
elements incorporated into the sultam precursors or via the cross metathesis partner selected.
3. Experimental Section
All air and moisture sensitive reactions were carried out in flame- or oven-dried glassware
under argon atmosphere using standard gas tight syringes, cannulas and septa. Stirring was
achieved with oven-dried, magnetic stir bars. CH3CN was purified by passage through the
Solv-Tek purification system employing activated Al2O3 (Grubbs, R. H.; Rosen, R. K.;
Timmers, F. J. Organometallics 1996, 15, 1518–1520). Et3N was purified by passage over
basic alumina and stored over KOH. Flash column chromatography was performed with
SiO2 obtained from Sorbent Technologies (30930M-25, Silica Gel 60A, 40–63 um). Metathesis
catalysts were provided by Materia, Inc. and used without further purification. Thin layer
chromatography was performed on silica gel 60F254 plates (EM-5717, Merck). Deuterated
solvents were purchased from Cambridge Isotope laboratories. 1H and 13C NMR spectra were
recorded on a Bruker DRX-400 spectrometer operating at 400 MHz and 100 MHz respectively;
or a Bruker Avance operating at 500 MHz and 125 MHz respectively. High-resolution mass
spectrometry (HRMS) and FAB spectra were obtained on a VG Instrument ZAB double-
focusing mass spectrometer. Melting points were obtained on a Thomas Hoover capillary
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melting point apparatus. Optical rotations were carried out on a Rudolph Automatic
Polarimeter (AUTOPOL IV).
6H-3a,6-Epoxy-1,2-benzisothiazole, 2,3,7,7a-tetrahydro-2-allyl, 1,1-dioxide [(±) 1]
Into a flame dried flask under argon was added furfurylamine (1.05 mL, 11.9 mmol), Et3N
(1.66 mL, 11.9 mmol), and dry CH2Cl2 (20 mL). After stirring at 0 °C for 10 min, 2-
chloroethanesulfonyl chloride (0.96 mL, 9.2 mmol) was added and the reaction flask stirred at
rt for 2 h. The crude reaction mixture was filtered and the filtrate was concentrated under
reduced pressure. The crude material was dissolved in dry CH3CN (50 mL, 0.2 M) to which
K2CO3 (3.9 g, 32.0 mmol) was added. After stirring for 5 mins, allyl bromide (2.8 mL, 32.0
mmol) was added and the reaction mixture was stirred at 60 °C, until SM disappeared as
monitored by TLC analysis. After such time, the crude reaction mixture was filtered through
a pad of celite, concentrated under reduced pressure and purified by flash chromatography (1:1
hexane:EtOAc) to yield 1 (1.15 g, 5.0 mmol, 55%) as a white solid. Mp 98 °C; FTIR (neat):
1442, 1301, 1068, 1137 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 6.53 (dd, J = 5.7, 1.7 Hz,
1H), 6.37 (d, J = 5.7 Hz, 1H), 5.88 (ddt, J = 16.6, 10.1, 6.4 Hz, 1H), 5.30 (ddq, J = 24.7, 10.1,
1.3 Hz, 2H), 5.23 (dd, J = 4.5, 1.7 Hz, 1H), 3.84 (d, J = 11.3 Hz, 1H), 3.80 – 3.75 (m, 2H),
3.62 (d, J = 11.3 Hz, 1H), 3.18 (dd, J = 7.9, 3.6 Hz, 1H), 2.61 – 2.55 (m, 1H), 1.81 (dd, J =
12.3, 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ ppm 139.5, 134.1, 132.4, 119.7, 90.5, 79.7,
60.5, 48.9, 47.6, 29.2; HRMS calculated for C10H13NNaO3S (M+Na)+ 250.0514; found
250.0518.
6H-3a,6-Epoxy-1,2-benzisothiazole, 2,3,7,7a-tetrahydro-2-propargyl, 1,1-dioxide [(±) 2]
Using a similar procedure as that used to produce sultam 1, N-(2-furanylmethyl)
ethanesulfonamide (1.0 g, 5.28 mmol), propargyl bromide (2.8 ml, 32.0 mmol) yielded 2 (68.9
mg, 3.0 mmol, 58%) as a white solid. Mp 150 °C; FTIR (neat): 3226, 1304, 1282, 1140
cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 6.55 (dd, J = 1.7, 5.7 Hz, 1H), 6.42 (d, J = 5.7 Hz,
1H), 5.26 (dd, J = 4.5, 1.6 Hz, 1H), 4.10 – 4.02 (m, 2H), 3.93 (dd, J = 17.7, 2.5 Hz, 1H), 3.81
(d, J = 11.4 Hz, 1H), 3.18 (dd, J = 7.9, 3.6 Hz, 1H), 2.61 – 2.55 (m, 1H), 2.37 (t, J = 2.5 Hz,
1H), 1.81 (dd, J = 12.4, 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ ppm 139.5, 134.1, 90.7,
79.8, 76.8, 74.1, 60.5, 48.8, 34.7, 29.1; HRMS calculated for C10H11NNaO3S (M+Na)+
248.0357; found 248.0347.
Sultam (3)
To a flame dried flask was added dry CH2Cl2 (95 mL, 0.005 M), which was degassed for 30
min with argon. After such time, sultam 1 (0.1 g, 0.44 mmol) and cat-B (0.04 g, 0.044 mmol)
were added and the reaction mixture was refluxed at 45 °C for 3 h. The crude reaction mixture
concentrated under reduced pressure and purified by flash chromatography (1:1
hexane:EtOAc) to provide 3 (15.7 mg, 0.36 mmol, 84% yield) as a white solid. Mp 227 °C;
FTIR (neat): 1336, 1164, 1112 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 6.28 (ddd, J = 10.1,
5.1, 2.1 Hz, 1H), 5.76 (ddd, J = 6.7, 3.4, 1.7 Hz, 1H), 5.55 (dt, J = 10.1, 2.5 Hz, 1H), 4.84 (d,
J = 6.0 Hz, 1H), 4.19 (dt, J = 19.5, 2.5 Hz, 1H), 3.79 (dt, J = 19.6, 2.2 Hz, 1H), 3.71 (dd, J =
11.0, 5.7 Hz, 1H), 3.59 (dd, J = 12.2, 1.9 Hz, 1H), 3.24 (dd, J = 12.2, 1.8 Hz, 1H), 2.71 (dddd,
J = 14.0, 8.1, 5.8, 2.1 Hz, 1H), 2.14 – 2.06 (m, 1H); 13C NMR (125 MHz, CDCl3) δ ppm 134.2,
134.2, 131.2, 130.9, 124.1, 124.1, 87.6, 80.9, 80.7, 71.0, 71.0, 51.9, 50.9, 34.1, 34.1; HRMS
calculated for C18H22N2NaO6S2 (M+Na)+ 449.0817; found 449.0816.
General Procedure A for ROM-RCM-CM metathesis cascade
To a flame dried flask was added dry CH2Cl2 (0.005 M), which was degassed for 30 min with
argon. To this was added, sultam (1 eq.), cat-B (10 mol%) and CM partner (10 eq.). The reaction
mixture was refluxed at 45 °C for 3 h. The crude reaction mixture was concentrated under
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reduced pressure and purified by flash chromatography (1:1 hexane: EtOAc) to afford the
desired compound.
Sultam [(±) 4]
According to general procedure A, 1 (80 mg, 0.3 mmol, cat-B (30 mg, 0.03 mmol) was added
to ethylene degassed, dry CH2Cl2 (85 mL, 0.005 M) to yield (±) 4 [50 mg, 0.22 mmol, 74%]
as a yellow solid. Mp 91 °C; FTIR (neat): 2925, 1350, 1338, 1166 cm−1; 1H NMR (500 MHz,
CDCl3) δ ppm 6.28 (dq, J = 10.1, 2.1 Hz, 1H), 5.80 (ddd, J = 17.0, 10.4, 6.4 Hz, 1H), 5.57 –
5.48 (m, 1H), 5.33 – 5.25 (m, 1H), 5.19 (dt, J = 10.4, 1.1 Hz, 1H), 4.82 (dd, J = 14.6, 6.9 Hz,
1H), 4.18 (dt, J = 19.5, 2.4 Hz, 1H), 3.76 (dt, J = 19.5, 2.2 Hz, 1H), 3.70 (ddd, J = 10.9, 6.0,
1.9 Hz, 1H), 3.59 (dd, J = 12.2, 2.0 Hz, 1H), 3.23 (dd, J = 12.2, 2.0 Hz, 1H), 2.68 (ddd, J =
14.0, 8.0, 6.0 Hz, 1H), 2.09 (ddd, J = 14.1, 10.9, 7.1 Hz, 1H); 13C NMR (125 MHz, CDCl3)
δ ppm 135.6, 133.5, 123.0, 116.4, 86.6, 81.4, 70.2, 51.1, 50.0, 33.0; HRMS calculated for
C10H13NNaO3S (M+Na)+ 250.0514; found 250.0507.
Sultam [(±) 5]
According to general procedure A, 1 (80 mg, 0.3 mmol, cat-B (30 mg, 0.03 mmol) and ethyl
acrylate (3.2 mL, 30 mmol) was added to argon degassed, dry CH2Cl2 (85 mL, 0.005 M) to
yield (±) 5 [58 mg, 0.19 mmol, 65%] as a pale yellow solid. Mp 232 °C; FTIR (neat): 1716,
1350, 1269, 1167 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 6.85 (dd, J = 15.6, 5.0 Hz, 1H),
6.30 (d, J = 10.1 Hz, 1H), 6.04 (d, J = 15.6 Hz, 1H), 5.57 (d, J = 10.1 Hz, 1H), 5.02 (dd, J =
6.7, 13.4 Hz, 1H), 4.24 – 4.16 (m, 3H), 3.82 – 3.75 (m, 1H), 3.75 – 3.69 (m, 1H), 3.62 – 3.56
(m, 1H), 3.30 – 3.25 (m, 1H), 2.83 – 2.74 (m, 1H), 2.21 – 2.12 (m, 1H), 1.32 – 1.27 (m,
3H); 13C NMR (125 MHz, CDCl3) δ ppm 165.9, 144.7, 134.0, 124.2, 121.7, 88.0, 80.0, 70.5,
60.8, 52.1, 51.0, 33.5, 14.2; HRMS calculated for C13H17NNaO5S (M+Na)+ 322.0725; found
322.0698.
Sultam [(±) 6]
According to general procedure A, 1 (80 mg, 0.3 mmol, cat-B (30 mg, 0.03 mmol) and methyl
acrylate (2.7 mL, 30 mmol) was added to argon degassed, dry CH2Cl2 (85 mL, 0.005 M) to
yield (±) 6 [48 mg, 0.16 mmol, 56%] as a pale yellow solid. Mp 144 °C; FTIR (neat): 1722,
1350, 1340, 1167 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 6.86 (d, J = 13.8 Hz, 1H), 6.30
(d, J = 8.0 Hz, 1H), 6.05 (d, J = 15.3 Hz, 1H), 5.56 (d, J = 7.9 Hz, 1H), 5.02 (s, 1H), 4.19 (d,
J = 19.2 Hz, 1H), 3.85 – 3.53 (m, 6H), 3.28 (d, J = 11.6 Hz, 1H), 2.78 (s, 1H), 2.16 (s,
1H); 13C NMR (125 MHz, CDCl3) δ ppm 166.3, 145.0, 133.9, 124.2, 121.2, 88.0, 80.0, 70.5,
52.1, 51.9, 50.9, 33.5; HRMS calculated for C12H15NNaO5S (M+Na)+ 308.0569; found
308.0562.
Sultam [(±) 7]
According to general procedure A, 1 (80 mg, 0.3 mmol, cat-B (30 mg, 0.03 mmol) and t-butyl
acrylate (4.3 mL, 30 mmol) was added to argon degassed, dry CH2Cl2 (85 mL, 0.005 M) to
yield (±) 7 [76 mg, 0.23 mmol, 78%] as a yellow oil. FTIR (neat): 2978, 1711, 1352, 1314,
1165 cm−1; 1H NMR (400 MHz, CDCl3) δ ppm 6.77 (dd, J = 15.6, 5.0 Hz, 1H), 6.34 (d, J =
10.2 Hz, 1H), 5.99 (d, J = 15.6 Hz, 1H), 5.59 (d, J = 10.3 Hz, 1H), 5.03 (s, 1H), 4.23 (d, J =
19.6 Hz, 1H), 3.87 – 3.71 (m, 2H), 3.62 (d, J = 12.5 Hz, 1H), 3.30 (d, J = 12.2 Hz, 1H), 2.80
(s, 1H), 2.19 (ddd, J = 14.0, 10.8, 6.6 Hz, 1H), 1.51 (s, 9H); 13C NMR (125 MHz, CDCl3) δ
ppm 165.1, 143.4, 134.1, 124.2, 123.6, 88.0, 81.0, 80.1, 76.8, 70.6, 52.1, 50.9, 33.5, 31.0, 28.1;
HRMS calculated for C15H21NNaO5S (M+Na)+ 350.1038; found 350.1030.
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According to general procedure A, 1 (80 mg, 0.3 mmol, cat-B (30 mg, 0.03 mmol) and styrene
(3.4 mL, 30 mmol) was added to argon degassed, dry CH2Cl2 (85 mL, 0.005 M) to yield (±)
8 [73 mg, 0.24 mmol, 81%] as a brown liquid. FTIR (neat): 1348, 1338, 1164, 1132, 968, 750
cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 7.39 (dd, J = 5.0, 3.4 Hz, 2H), 7.35 – 7.31 (m, 2H),
7.28 (dt, J = 4.7, 1.9 Hz, 1H), 6.64 (d, J = 15.8 Hz, 1H), 6.34 (dq, J = 10.1, 2.1 Hz, 1H), 6.15
(dd, J = 15.8, 7.0 Hz, 1H), 5.56 (dt, J = 10.1, 2.5 Hz, 1H), 5.01 (q, J = 7.2 Hz, 1H), 4.22 (dt,
J = 19.5, 2.5 Hz, 1H), 3.84 – 3.74 (m, 2H), 3.66 (dd, J = 12.2, 2.0 Hz, 1H), 3.28 (dd, J = 12.2,
2.0 Hz, 1H), 2.78 (ddd, J = 13.9, 8.0, 5.7 Hz, 1H), 2.21 (ddd, J = 14.2, 11.1, 7.3 Hz, 1H); 13C
NMR (125 MHz, CDCl3) δ ppm 135.9, 134.4, 132.8, 128.9, 128.3, 127.3, 126.7, 124.0, 87.5,
82.2, 71.3, 51.9, 51.0, 34.4; HRMS calculated for C16H17NNaO3S (M+Na)+ 326.0827; found
326.0795.
Sultam [(±) 9]
According to general procedure, 1 (80 mg, 0.3 mmol, cat-B (30 mg, 0.03 mmol) and 4-
bromostyrene (3.9 mL, 30 mmol) was added to argon degassed, dry CH2Cl2 (85 mL, 0.005 M)
to yield (±) 9 [87 mg, 0.23 mmol, 80%] as a white solid. Mp 140 °C; FTIR (neat): 1487, 1350,
1338, 1164, 744 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 7.48 – 7.43 (m, 2H), 7.25 (dt, J =
9.0, 2.2 Hz, 2H), 6.58 (d, J = 15.8 Hz, 1H), 6.33 (dq, J = 10.1, 2.1 Hz, 1H), 6.14 (dd, J = 15.8,
6.9 Hz, 1H), 5.57 (dt, J = 10.1, 2.5 Hz, 1H), 4.99 (q, J = 7.1 Hz, 1H), 4.22 (dt, J = 19.5, 2.5
Hz, 1H), 3.84 – 3.73 (m, 2H), 3.65 (dd, J =12.2, 2.0 Hz, 1H), 3.28 (dd, J = 12.2, 2.0 Hz, 1H),
2.77 (ddd, J = 13.9, 8.0, 5.7 Hz, 1H), 2.19 (ddd, J = 114.2, 11.1, 7.4 Hz, 1H); 13C NMR (125
MHz, CDCl3) δ ppm 134.8, 134.3, 131.8, 131.5, 128.2, 128.1, 124.1, 122.1, 87.6, 81.9, 71.2,
51.9, 51.0, 34.3; HRMS calculated for C16H16BrNNaO3S (M+Na)+ 403.9932; found
403.9619.
Sultam [(±) 10]
According to general procedure A, 1 (80 mg, 0.3 mmol, cat-B (30 mg, 0.03 mmol) and
acrylonitrile (1.9 mL, 30 mmol) was added to argon degassed, dry CH2Cl2 (85 mL, 0.005 M)
to yield (±) 10 [50 mg, 0.20 mmol, 67%] as a white solid. Mp 170 °C; FTIR (neat): 1338, 1164,
1114 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 6.67 (dd, J = 16.2, 4.3 Hz, 1H), 6.28 (dq, J =
10.1, 2.1 Hz, 1H), 5.67 (dd, J = 1.9, 16.2 Hz, 1H), 5.60 (dt, J = 10.1, 2.5 Hz, 1H), 5.03 – 4.96
(m, 1H), 4.21 (dt, J = 19.6, 2.5 Hz, 1H), 3.80 (dt, J = 19.6, 2.2 Hz, 1H), 3.72 (ddd, J = 10.8,
6.4, 1.9 Hz, 1H), 3.58 (dd, J = 2.0, 12.3 Hz, 1H), 3.29 (dd, J = 2.0, 12.3 Hz, 1H), 2.86 – 2.79
(m, 1H), 2.16 (ddd, J = 14.1, 10.9, 6.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ ppm 149.9,
132.3, 123.5, 115.4, 99.4, 87.1, 78.4, 69.1, 50.9, 49.9, 32.2; HRMS calculated for
C11H12N2NaO3S (M+Na)+ 275.0466; found 275.0468.
Sultam [(±) 12]
According to general procedure A, 2 (80 mg, 0.3 mmol, cat-B (30 mg, 0.03 mmol) was added
to argon degassed, dry CH2Cl2 (85 mL, 0.005 M) to yield (±) 12 [63 mg, 0.23 mmol, 75%] as
a brown liquid. FTIR (neat): 2927, 1597, 1311, 1150, 931 cm−1; 1H NMR (500 MHz,
CDCl3) δ ppm 6.36 (dd, J = 17.7, 11.1 Hz, 1H), 5.99 (dd, J = 17.0, 10.6 Hz, 1H), 5.81 (ddd,
J = 17.2, 10.3, 6.9 Hz, 1H), 5.57 – 5.44 (m, 2H), 5.33 (dd, J = 17.2, 1.1 Hz, 1H), 5.28 – 5.16
(m, 5H), 4.71 – 4.65 (m, 1H), 4.15 (d, J = 13.8 Hz, 1H), 3.53 (d, J = 8.6 Hz, 1H), 3.47 (d, J =
13.8 Hz, 1H), 3.28 (d, J = 10.9 Hz, 1H), 3.10 (d, J = 10.9 Hz, 1H), 2.70 (dd, J = 5.0, 13.7 Hz,
1H), 2.00 (ddd, J = 8.7, 10.8, 13.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ ppm 139.4, 137.3,
136.2, 136.0, 119.9, 118.1, 116.4, 115.7, 85.7, 81.8, 66.6, 56.7, 44.7, 35.1; HRMS calculated
for C14H19NNaO3S(M+Na)+ 304.0983; found 304.0947.
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To a flame dried flask containing dry toluene (0.5 mL) was added diene 12 (30 mg, 0.1 mmol)
and N-phenylmaleimide (0.23 g, 0.13 mmol). The reaction was heated at 85 °C for 24 h. The
crude reaction mixture was concentrated under reduced pressure and purified by flash
chromatography (3:2 hexane:EtOAc) to yield 13 (38 mg, 8.3 × 10−5 mol, 83% yield) as a yellow
oil. FTIR (neat): 1709, 1498, 1383, 1309, 1147 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 7.43
(dd, J = 8.0, 16.5 Hz, 2H), 7.36 (dd, J = 7.5, 15.2 Hz, 1H), 7.32 – 7.27 (m, 1H), 7.22 (d, J =
7.3 Hz, 1H), 5.94 (td, J = 10.8, 16.7 Hz, 2H), 5.80 (dddd, J = 6.8, 10.4, 13.4, 17.0 Hz, 1H),
5.56 – 5.47 (m, 1H), 5.37 (dd, J = 17.2, 22.0 Hz, 1H), 5.28 – 5.13 (m, 2H), 4.79 – 4.71 (m,
1H), 3.81 (d, J = 14.1 Hz, 1H), 3.52 (d, J = 8. Hz, 1H), 3.42 – 3.22 (m, 3H), 3.16 (dd, J = 5.5,
10.8 Hz, 1H), 3.06 (dd, J = 3.0, 10.8 Hz, 1H), 2.76 – 2.64 (m, 3H), 2.47 – 2.32 (m, 2H), 2.00
(ddd, J = 7.7, 14.1, 17.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ ppm 178.8, 178.7, 178.4 (2),
137.3, 137.2, 136.3, 136.2, 134.4, 134.0, 131.9 (2), 129.1, 129.0, 128.6, 128.5, 126.4 (2), 125.7,
125.6, 118.2, 117.8, 116.6, 116.5, 86.0, 85.7, 82.2, 81.7, 66.7 (2), 57.9, 57.0, 49.5, 49.2, 39.4,
39.0, 38.9 (2), 34.9, 34.8, 25.6 (2), 24.3, 24.1; HRMS calculated for C24H26N2NaO5S (M
+Na)+ 477.1460; found 477.1436.
Sultam [(±) 15]
To a flame dried flask under argon was added furfural (1.72 mL, 20.8 mmol), 4-
methoxybenzylamine (2.7 mL, 20.8 mmol), MgSO4 (3.0 g) and dry CH2Cl2 (20 mL). After
stirring at RT for 6 h, the crude reaction mixture was filtered and the filtrate was concentrated
under reduced pressure. The crude was dissolved in THF (20 mL) to which was added allyl
magnesium bromide (5.57 mL, 11.15 mmol). The reaction mixture was stirred for 5 h. after
which time NH4Cl (sat. aq., 10 mL) was added. The aqueous layer was extracted with
CH2Cl2 (4 × 20 mL) and the combined organic layer was dried (MgSO4). The crude reaction
mixture 14 (1.2 g) was solvated in dry toluene (5 mL) and heated at reflux for 12 h. After such
time the crude reaction mixture concentrated under reduced pressure and purified by flash
chromatography (1:1 hexane:EtOAc) to provide the desired compound (95% yield) as a yellow
liquid. FTIR (neat): 1612, 1514, 1301, 1247, 1137 cm−1; [Mixture of Diastereoisomers
(1:1)] 1H NMR (500 MHz, CDCl3) δ ppm 7.37 (d, J = 8.6 Hz, 1H), 7.32 (d, J = 8.6 Hz, 1H),
6.95 – 6.81 (m, 4H), 6.52 (dd, J = 5.8, 1.7 Hz 1H), 6.47 – 6.38 (m, 3H), 6.18 (d, J = 5.7 Hz,
1H), 5.93 – 5.78 (m, 1H), 5.74 – 5.58 (m, 1H), 5.28 (dd, J = 4.5, 1.5 Hz 1H), 5.22 – 5.14 (m,
2H), 5.09 – 4.97 (m, 2H), 4.51 (d, J = 15.7 Hz, 1H), 4.41 (d, J = 15.3 Hz, 1H), 4.28 (dd, J =
15.5, 8.7 Hz 2H), 3.81 (dd, J = 8.9, 5.6 Hz, 6H), 3.72 (t, J = 5.3 Hz, 1H), 3.24 (dd, J = 7.9, 3.2
Hz, 1H), 3.13 (dd, J = 7.8, 3.3 Hz, 1H), 2.74 – 2.59 (m, 1H), 2.56 – 2.48 (m, 1H), 2.45 (t, J =
7.2 Hz, 1H), 1.80 (td, J = 12.4, 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ ppm 159.3, 159.2,
139.7, 137.9, 135.3, 132.9, 132.6, 132.1, 130.0, 129.9, 127.6, 127.3, 119.4, 118.9, 114.1, 114.1,
94.5, 92.2, 79.4, 78.8, 60.4, 59.7, 58.6, 58.4, 55.3, 55.3, 46.6, 46.0, 34.6, 33.8, 30.1, 29.5;
HRMS calculated for C18H21NNaO4S (M+Na)+ 370.1089; found 370.1075.
Sultam [(±) 16]
According to general procedure A, 15 (0.06 g, 0.17 mmol), cat-B (0.015 g, 0.017 mmol) in
ethylene degassed CH2Cl2 (35 mL). The crude reaction was purified by flash chromatography
(2:1 hexane:EtOAc) to provide 16 (32 mg, 54%) and 17 (10 mg, 16%). FTIR (neat): 1612,
1514, 1305, 1249, 1149 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 7.42 – 7.22 (m, 2H), 7.11
– 6.74 (m, 2H), 6.10 – 5.87 (m, 1H), 5.80 (ddd, J = 17.1, 10.4, 6.6 Hz, 1H), 5.72 (dt, J = 5.7,
2.2 Hz, 1H), 5.30 (dt, J = 17.2, 1.2 Hz, 1H), 5.23 – 5.15 (m, 1H), 4.52 – 4.38 (m, 2H), 4.05 (d,
J = 14.4 Hz, 1H), 3.82 (d, J = 5.2 Hz, 3H), 3.64 – 3.54 (m, 2H), 2.75 (ddd, J = 13.8, 5.5, 2.0
Hz, 1H), 2.64 – 2.43 (m, 2H), 2.12 (dt, J = 13.8, 9.9 Hz, 1H); 13C NMR (125 MHz, CDCl3)
δ ppm 159.5, 135.9, 135.1, 130.4, 130.2, 126.8, 118.0, 114.1, 97.3, 80.1, 64.6, 63.8, 55.3, 45.4,
35.5, 35.2; HRMS calculated for C18H21NNaO4S (M+Na)+ 370.1089; found 370.1087.
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FTIR (neat): 1514, 1303, 1247, 1145 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 7.31 (d, J =
8.7 Hz, 2H), 6.90 – 6.85 (m, 2H), 5.97 – 5.81 (m, 2H), 5.72 (dddd, J = 11.7, 9.5, 7.5, 6.4 Hz,
1H), 5.56 – 5.48 (m, 1H), 5.39 (ddd, J = 12.5, 4.3, 3.1 Hz, 2H), 5.27 – 5.20 (m, 1H), 5.00 –
4.92 (m, 2H), 4.76 (dd, J = 11.0, 5.9 Hz, 1H), 4.42 (d, J = 15.8 Hz, 1H), 4.10 (d, J = 15.8, 1H),
3.84 – 3.78 (s, 3H), 3.55 (d, J = 8.4 Hz, 1H), 3.38 (dd, J = 7.4, 5.2 Hz 1H), 2.75 (ddd, J = 13.6,
5.1, 0.9 Hz, 1H), 2.47 – 2.38 (m, 1H), 2.34 – 2.26 (m, 1H), 2.02 (ddd, J = 13.6, 10.8, 8.5 Hz,
1H); 13C NMR (125 MHz, CDCl3) δ ppm 159.5, 139.1, 136.8, 129.8, 118.1, 118.1, 117.1,
114.3, 88.5, 82.4, 66.9, 66.1, 55.7, 46.0, 35.1, 32.5; HRMS calculated for C20H25NNaO4S (M
+Na)+ 398.1402; found 398.1401.
Sultam [(±) 18]
According to general procedure A, 15 (80 mg, 0.3 mmol), cat-B (30 mg, 0.03 mmol), ethyl
acrylate (3.0 mL, 30 mmol) was added to argon degassed, dry CH2Cl2 (85 mL, 0.005 M) to
yield (±) 18 [61 mg, 0.147 mmol, 49%] as a yellow oil. FTIR (neat): 1718, 1514, 1303, 1149
cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 7.28 – 7.24 (m, 2H), 6.90 – 6.82 (m, 3H), 6.01 (ddd,
J = 9.7, 7.9, 1.9 Hz, 2H), 5.71 (dt, J = 2.2, 5.7 Hz, 1H), 4.65 – 4.60 (m, 1H), 4.46 (d, J = 14.4
Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 4.04 (d, J = 14.4 Hz, 1H), 3.81 (s, 3H), 3.63 (dd, J = 9.7,
1.9 Hz, 1H), 3.59 (dd, J = 7.2, 3.7 Hz, 1H), 2.63 – 2.44 (m, 3H), 2.14 (dt, J = 13.8, 9.9 Hz,
1H), 1.28 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ ppm 165.9, 159.5, 144.1, 135.4,
130.2 130.1, 126.7, 122.2, 114.2, 97.8, 76.8, 64.6, 63.6, 60.7, 55.3, 45.5, 35.3, 35.2, 14.2;
HRMS calculated for C21H25NNaO6S (M+Na)+ 442.1300; found 442.1283.
Sultam [(±) 19]
According to general procedure A, 15 (80 mg, 0.3 mmol), cat-B (30 mg, 0.03 mmol), t-butyl
acrylate (4.3 mL, 30 mmol) was added to argon degassed, dry CH2Cl2 (85 mL, 0.005 M) to
yield (±) 19 [69 mg, 0.156 mmol, 52%] as a yellow oil. FTIR (neat): 2978, 1710, 1514, 1308,
1151 cm−1. 1H NMR (500 MHz, CDCl3) δ ppm 7.27 – 7.23 (m, 2H), 6.90 – 6.85 (m, 2H), 6.74
(dd, J = 15.7, 5.3 Hz, 1H), 6.01 – 5.98 (m, 1H), 5.94 (dd, J = 15.7, 1.4 Hz, 1H), 5.71 (dt, J =
5.7, 2.2 Hz, 1H), 4.59 (dd, J = 7.3, 2.7 Hz, 1H), 4.46 (d, J = 14.4 Hz, 1H), 4.03 (d, J = 14.4
Hz, 1H), 3.81 (s, 3H), 3.62 (dd, J = 19.7, 1.9 Hz, 1H), 3.57 (dd, J = 7.2, 3.8 Hz, 1H), 2.80 (ddd,
J = 13.8, 5.8, 2.0 Hz, 1H), 2.60 – 2.46 (m, 1H), 2.13 (dt, J = ,13.8, 9.9 Hz, 1H), 1.87 – 1.82
(m, 1H), 1.46 (s, 9H); 13C NMR (125 MHz, CDCl3) δ ppm 165.2, 159.5, 142.9, 135.4, 130.2,
130.1, 126.7, 124.1, 114.2, 97.7, 80.8, 76.8, 64.6, 63.6, 55.3, 45.4, 35.2, 35.2, 28.1; HRMS
calculated for C23H29NNaO6S (M+Na)+ 470.1613; found 470.1601.
tert-Butyl (2S)-1-(furan-2-yl)-1-hydroxy-3-phenylpropan-2-ylcarbamate (20)
To a stirring suspension of imidazole (12.8 g, 188 mmol) in CH2Cl2 (40 mL) was added a
solution of PhOP(O)Cl2 (5.61 mL, 37.7 mmol) in CH2Cl2 (40 mL). After stirring for 1 h, the
reaction was cooled to 0 °C and a solution of Boc-phenylalanine (10.0 g, 37.7 mmol) in
CH2Cl2 (28 mL) was added and the reaction mixture stirred for 1 h. After such time, Weinreb
amine (3.68 g, 37.7 mmol) was added and the reaction stirred at rt for 14 h. The reaction was
quenched with citric acid (2M aq., 80 mL), the organic layer washed with NaHCO3 (1M aq.,
80 mL) and brine (80 mL). The organic layer was dried (MgSO4), filtered and concentrated
under reduced pressure to generate the desired intermediate as a clear oil (crude NMR analysis).
A portion of the crude (6.59 g, 25.3 mmol) in THF (84.5 mL) was cooled to −40 °C was stirred
for 30 min. In a separate round bottom flask, a solution of furan (4.6 mL, 63.3 mmol) in THF
(110 mL) was cooled to −78 °C to which nBuLi (26.3 mL) was added slowly and upon
completion, was stirred for 30 min. After such time, this solution was added slowly to the crude
mixture at −40 °C and the reaction mixture was subsequently stirred for an additional 6 h. After
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such time the reaction was quenched with NH4Cl (sat. aq., 80 mL) and the reaction mixture
warmed to RT. The aqueous layer was extracted with EtOAc (3 × 120 mL) and the combined
organic layers were dried (MgSO4), filtered and concentrated under reduced pressure to give
the desired intermediate as a clear oil (crude NMR analysis). A portion of the crude (1.0 g) in
THF (12 mL)/MeOH (1.5 mL) was cooled to 0 °C and after stirring for 15 min, NaBH4 (0.14
g, 3.8 mmol) was added and reaction stirred for 2 h at 0 °C. After such time the reaction was
warmed to RT, diluted with EtOAc (10 mL) followed by HCl (10% aq., 10 mL). After stirring
for 15 min, the organic layer was washed with HCl (10% aq., 10 mL), H2O (10 mL),
NaHCO3 (sat. aq., 10 mL) and brine (10 mL). The combined organic layers were dried
(MgSO4), filtered and concentrated under reduced pressure to yield the desired intermediate
as a white solid. Mp 144–146 °C; FTIR (neat) 1716, 1454, 1292, 1172, 1132 cm−1; [Major
Isomer] 1H NMR (500 MHz, CDCl3) δ 7.48 – 7.43 (m, 1H), 7.34 – 7.17 (m, 5H), 6.38 – 6.29
(m, 2H), 4.80 (d, J = 19.2 Hz, 1H), 4.70 – 4.78 (m, 1H), 4.27 (br s, 1H), 3.55 (br s, 1H), 2.80
(d, J = 6.3 Hz, 2H), 1.35 (s, 9H). [Minor Isomer] 1H NMR (500 MHz, CDCl3) δ 7.39 (s, 1H),
7.16 – 7.35 (m, 5H), 6.43 – 6.38 (m, 2H), 4.89 (s, 1H), 4.75 (s, 1H), 4.14 (s, 1H), 3.08 (s, 1H),
2.88 – 2.99 (m, 2H), 1.41 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 156.6, 154.6, 154.0, 142.3,
142.0, 137.9, 137.6, 129.3, 129.3, 128.5, 128.5, 126.5, 126.5, 110.3, 107.8, 106.8, 80.0, 79.7,
77.3, 77.0, 76.7, 70.1, 68.7, 56.5, 55.4, 37.6, 36.6, 28.3; HRMS calculated for C18H23NO4Na
(M + Na) + 340.1525; found 340.1520 (TOF MS ES+).
7H-4a,7-Epoxy-2H-1,2-benzothiazin-4-ol, 3,4,8,8a-tetrahydro-3-(phenylmethyl)-, 1,1-dioxide,
(3S,4R) (21)
Carbamate 20 (2.0 g, 6.3 mmol) was dissolved in CH2Cl2 (32 mL), cooled to 0 °C and after
stirring for 15 min TFA (1.95 mL, 25.2 mmol) was added cautiously. After stirring at RT for
3 h, the reaction was cooled to 0 °C and NaOH (10% aq., 35 mL) was added. The reaction was
diluted with CH2Cl2 (32 mL), the aqueous layer extracted with CH2Cl2 (2 × 30 mL) and the
combined organic dried (MgSO4), filtered and concentrated under reduced pressure to afford
the desired carbamate intermediate as a white solid. The crude product (1.78 g) was dissolved
in EtOH (40 mL) and NaOH (1M aq., 40 mL) was added. After stirring at reflux for 14 h, the
organic solvent was removed under reduced pressure. The resulting aqueous layer was
extracted with CH2Cl2 (3 × 30 mL) and the combined organic layers were dried (MgSO4),
filtered and concentrated under reduced pressure to produce the desired amino alcohol
intermediate as a yellow oil. The crude material was dissolved in CH2Cl2 (11.7 mL), to which
was added Et3N (1.58 mL, 91 mmol) and the reaction was cooled to 0 °C. After stirring for 10
mins, 2-chloroethanesulfonyl chloride (0.52 mL, 4.89 mmol) was added drop wise over 5 min.
The reaction mixture was warmed to RT and stirred for 12 hours. After which time the crude
mixture was concentrated and purified by flash chromatography (1:2 hexane:EtOAc) to yield
(1.0 g, 3.2 mmol, 52%) of 21 as a white solid. FTIR (neat) 3480, 3350, 2358, 1448, 1305, 1139
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.28 (m, 2H), 7.28 – 7.19 (m, 3H), 6.55 (dd, J =
5.7, 1.5 Hz, 1H), 6.34 (d, J = 5.7 Hz, 1H), 5.19 (dd, J = 4.7, 1.5 Hz, 1H), 4.64 (d, J = 10.6 Hz,
1H), 4.07 (dd, J = 16.4, 9.7 Hz 1H), 3.90 (s, 1H), 3.21 (dd, J = 7.9, 3.2 Hz 1H), 3.10 (dd, J =
13.9, 6.6 Hz, 1H), 2.92 (dd, J = 13.8, 8.9 Hz, 1H), 2.61 – 2.52 (m, 1H), 2.35 (s, 1H), 1.77 (dd,
J = 12.2, 7.9 Hz 1H); 13C NMR (125 MHz, CDCl3) δ 140.1, 136.1, 133.4, 129.1, 129.0, 127.2,
91.2, 79.5, 64.2, 56.2, 55.6, 37.0, 28.8.; HRMS calculated for C15H17NO4SNa (M + Na)+
330.0776; found 330.2017 (TOF MS ES+).
Sultam [22]
Into a 1 dram vial was added 21 (85 mg, 0.27 mmol), DMF (0.6 mL, 0.46 M), Cs2CO3 (0.18
g, 0.55 mmol) and allyl bromide (25 μL, 0.30 mmol). The reaction was heated at 50 °C and
stirred for 4 h after which time the crude mixture was filtered and concentrated under reduced
pressure. The resulting crude oil was purified by flash chromatography (1:2 hexane:EtOAc)
to yield (86 mg, 2.48 mmol, 92%) of 22 as a yellow oil. FTIR (neat) 3386, 3249, 2358, 1336,
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1315, 1152 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.30 (m, 2H), 7.25 (dd, J = 7.2, 5.2
Hz 3H), 6.57 (dt, J = 5.6, 2.8 Hz 1H), 6.27 (d, J = 5.7, 1H), 6.04 – 5.94 (m, 1H), 5.33 (ddq, J
= 20.2, 10.4, 1.4 Hz 2H), 5.21 (dd, J = 4.7, 1.6 Hz 1H), 4.71 (d, J = 12.1 Hz, 1H), 4.31 (dt, J
= 5.5, 1.4 Hz, 2H), 4.14 (dddd, J = 12.1, 8.3, 7.1, 1.0 Hz, 1H), 3.64 (s, 1H), 3.20 (dd, J = 7.9,
3.3 Hz, 1H), 3.11 (dd, J = 14.3, 7.1 Hz, 1H), 2.90 (dd, J = 14.3, 8.5 Hz, 1H), 2.60 (ddd, J =
12.2, 4.6, 3.4 Hz, 1H), 1.78 (dd, J = 12.1, 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 140.3,
136.5, 133.6, 133.4, 129.1, 129.0, 127.1, 118.2, 91.0, 79.5, 74.9, 72.5, 56.7, 56.1, 37.4, 29.0;
HRMS calculated for C18H21NO5SNa (M + Na)+ 370.1089; found 370.1087 (TOF MS ES+).
Sultam [23]
According to general procedure A, sultam 22 (20 mg) underwent ROM-RCM-CM with
ethylene to yield 23 (18 mg, 90%) as a clear oil. FTIR (neat): 3481, 2975, 1724 1445, 1308,
1139 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.17 (m, 3H), 7.14 (ddd, J = 9.5, 6.6, 3.4
Hz, 2H), 6.46 (d, J = 5.7 Hz, 1H), 6.37 (dd, J = 5.7, 1.6 Hz, 1H), 5.75 (dddd, J = 17.2, 10.0,
7.6, 5.7 Hz, 1H), 5.16 (ddd, J = 13.6, 11.0, 1.1 Hz, 2H), 5.02 (dd, J = 4.6, 1.6 Hz, 1H), 4.03 –
3.90 (m, 3H), 3.80 – 3.70 (m, 2H), 3.25 – 3.16 (m, 2H), 3.01 (dd, J = 13.4, 5.1 Hz 1H), 2.18
(dt, J = 12.7, 4.4 Hz, 1H), 1.87 (dd, J = 12.7, 8.5 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ
137.9, 137.3, 135.3, 134.9, 129.4, 128.6, 126.7, 118.6, 91.6, 78.4, 64.2, 62.9, 57.3, 53.6, 37.1,
30.8; HRMS calculated for C18H21NO4SNa (M + Na)+ 370.1089; found 370.1087 (TOF MS
ES+).
Sultam [24]
To a stirring solution of sultam 21 (50 mg, 0.16 mmol), Et3N (45 μL, 0.32 mmol), and
CH2Cl2 (0.35 mL) in a 1 dram vial was added was added acryloyl chloride (17 μL, 0.21 mmol).
After stirring for 4 h at RT, the reaction mixture was concentrated under reduced pressure and
purified by flash chromatography (1:1 hexane:EtOAc) to yield (53 mg, 0.14 mmol, 92%) of
24 as a yellow oil. FTIR (neat): 3470, 2980, 1726 1452, 1300, 1140 cm−1; 1H NMR (400 MHz,
CDCl3) δ 7.32 – 7.22 (m, 3H), 7.17 (dd, J = 6.6, 5.0 Hz, 2H), 6.62 (dd, J = 17.3, 1.0 Hz 1H),
6.54 (dd, J = 5.8, 1.6 Hz, 1H), 6.27 (dd, J = 17.3, 10.4 Hz, 1H), 6.06 (dd, J = 10.4, 1.0 Hz, 1H),
5.95 (d, J = 5.8 Hz, 1H), 5.48 (d, J = 19.2 Hz, 1H), 5.22 (dd, J = 4.7, 1.6 Hz 1H), 4.64 (d, J =
11.6 Hz, 1H), 4.21 (dtd, J = 11.6, 7.3, 1.0 Hz, 1H), 3.19 (dd, J = 7.9, 3.2 Hz, 1H), 2.84 (qd, J
= 14.3, 7.3 Hz, 2H), 2.67 – 2.57 (m, 1H), 1.79 (dd, J = 12.2, 7.9 Hz, 1H); 13C NMR (125 MHz,
CDCl3) δ 137.9, 137.2, 135.3, 134.9, 129.4, 128.6, 126.7, 118.6, 91.6, 78.4, 64.2, 62.9, 57.3,
53.6, 37.1, 30.8; HRMS calculated for C18H19NO5SNa (M + Na)+ 384.0882; found 384.0886
(TOF MS ES+).
Sultam [25]
According to general procedure A, sultam 24 (18 mg) underwent ROM-RCM-CM with
ethylene to yield 25 (16 mg, 85%) as a clear oil. FTIR (neat): 3480, 2982, 1726 1448, 1305,
1139 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.23 (t, J = 7.3 Hz, 2H), 7.16 (dd, J = 15.3, 7.9 Hz,
1H), 7.11 (d, J = 7.1 Hz, 2H), 6.43 (dd, J = 17.2, 0.9 Hz, 1H), 6.08 (dd, J = 17.2, 10.4 Hz 1H),
5.91 (dd, J = 10.4, 0.9 Hz, 1H), 5.77 – 5.69 (m, 1H), 5.66 (dd, J = 17.4, 10.8 Hz, 1H), 5.26 (d,
J = 17.4 Hz, 1H), 5.19 (dd, J = 13.9, 7.4 Hz, 2H), 5.09 (d, J = 10.2 Hz, 1H), 5.07 (s, 1H), 4.93
(dd, J = 16.2, 7.8 Hz, 1H), 4.36 (d, J = 12.1 Hz, 1H), 4.27 – 4.19 (m, 1H), 3.63 (d, J = 6.6 Hz,
1H), 2.73 – 2.60 (m, 3H), 2.03 (ddd, J = 14.0, 9.5, 6.7 Hz, 1H); 13C NMR (125 MHz,
CDCl3) δ 164.2, 138.9, 138.3, 135.6, 133.2, 129.1, 128.7, 127.0, 127.0, 118.2, 118.1, 87.1,
81.4, 77.3, 61.8, 54.7, 37.5, 32.8; HRMS calculated for C20H23NO5SNa (M + Na)+ 412.1195;
found 412.1190 (TOF MS ES+).
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xxiii Into a flame dried flask under argon was added methanesulfonyl chloride (2.03 mL, 26.2
mmol), Et3N (4.4 mL, 31.6 mmol) and dry CH2Cl2 (70 mL). After cooling down to 0 °C,
furfurylamine (2.32 mL, 26.1 mmol) was added and the reaction flask stirred at room
temperature for 5 h. After such time, the crude reaction mixture was washed with water and
the organic layer dried (MgSO4), filtered and concentrated under reduced pressure to yield a
yellow oil. The crude material was subsequently dissolved in CH3CN (100 mL), to which
K2CO3 (7.27 g, 52.6 mmol) and allyl bromide (3.0 mL, 34.6 mmol) was added. After stirring
at 60 °C for 12 h, the crude reaction mixture was filtered through a pad of celite and washed
with CH2Cl2. The crude mixture was concentrated under reduced pressure and purified by flash
chromatography (4:1 hexane:EtOAc) to provide (5.35 g, 24.8 mmol, 95 % yield) as a yellow
oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.43 – 7.40 (m, 1H), 6.36 (dd, J = 3.1, 1.9 Hz, 1H),
6.31 (d, J = 3.2 Hz, 1H), 5.78 (ddt, J = 16.4, 10.1, 6.3 Hz, 1H), 5.30 (ddd, J = 10.9, 8.7, 1.3
Hz 2H), 4.42 (s, 2H), 3.82 (d, J = 6.2 Hz, 2H), 2.79 (s, 3H); 13C NMR (125 MHz, CDCl3) δ
ppm 149.7, 142.9, 132.6, 119.4, 110.5, 110.0, 49.3, 42.5, 39.4; HRMS calculated for
C9H13NNaO3S (M+Na)+ 238.0514; found 238.0510.
Sultam [(±) 28]
To a flame dried flask was added, 26 (2 g, 9.29 mmol), diethyl chlorophosphate (1.6 mL, 11.1
mmol) and THF (40 mL). The reaction mixture was cooled to −78 °C and after stirring for 15
mins, LHMDS (1.0 M solution in THF) was added. The resulting solution was warmed to 0 °
C and maintained for 2 h. To another flame dried flask, ethyl glyoxalate (3.7 mL, 18.7 mmol)
and THF (40 mL) were added at −78 °C. After stirring for 15 min, this solution was added to
the anionic solution containing 26 via cannula. The resulting solution was stirred at −78 °C for
7 h and then warmed to rt and stirred for an additional for 18 h. After such time, NH4Cl (sat.
aq., 25 mL) was added and the mixture was extracted with CH2Cl2 (4 × 25 mL). The organic
layer was dried (MgSO4), filtrated, concentrated under reduced pressure and purified by flash
chromatography (7:1 hexane:EtOAc) to provide the mixture of Diels-Alder product 28 and
precursor 27 product. Addition of hexane and Et2O followed by cooling at 0 °C, resulted in
crystallization of the desired product 28 as a white solid (1.55g, 5.2 mmol, 56%). FTIR (neat):
2983, 1736, 1301, 1141, 1020 cm−1; 1H NMR (500 MHz, CDCl3) δ ppm 6.51 (d, J = 5.7 Hz,
1H), 6.48 (dd, J = 5.7, 1.5 Hz, 1H), 5.88 (ddt, J = 16.6, 10.1, 6.4 Hz, 1H), 5.40 (dd, J = 4.7,
1.4 Hz 1H), 5.34 (dd, J = 17.1, 1.3 Hz, 1H), 5.29 (dd, J = 10.1, 1.0 Hz, 1H), 4.20 – 4.12 (m,
2H), 3.84 (dd, J = 9.9, 5.9 Hz, 2H), 3.81 – 3.77 (m, 2H), 3.62 (d, J = 11.5 Hz, 1H), 3.55 (d, J
= 3.7 Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ ppm 168.8, 137.4,
135.6, 132.2, 119.9, 91.8, 81.0, 63.4, 61.8, 48.8, 48.3, 47.7, 14.2; HRMS calculated for
C13H17NNaO5S (M+Na)+ 322.0725; found 322.0721.
Sultam [(±) 29]
To a flame dried flask was added dry CH2Cl2 (50 mL, 0.005 M), which was degassed with
ethylene 30 min. After such time, sultam 28 (0.1 g, 0.33 mmol) and cat-B (0.03 g, 0.033 mmol)
were added and the reaction was refluxed at 40 °C for 1 h under ethylene (1 atm). After cooling
to rt, the crude reaction mixture concentrated under reduced pressure and purified flash
chromatography (6:1 hexane:EtOAc) to yield 29 (58 mg, 1.94 mmol, 59% yield) as a grey
solid. Mp 155 °C; FTIR (neat): 2978, 1732, 1340, 1194, 999 cm−1; 1H NMR (500 MHz,
CDCl3) δ ppm 6.34 (dq, J = 10.1, 2.1 Hz, 1H), 5.73 (ddd, J = 17.2, 10.4, 6.8 Hz, 1H), 5.58 (dt,
J = 2.5, 10.1, 1H), 5.39 (dt, J = 17.1, 1.2 Hz, 1H), 5.27 (dt, J = 10.4, 1.1 Hz 1H), 5.08 (dd, J =
8.2, 7.4 Hz, 1H), 4.21 (ddd, J = 6.7, 5.7, 1.9 Hz 1H), 4.18 – 4.12 (m, 3H), 3.82 – 3.75 (m, 2H),
3.57 (dd, J = 12.3, 2.0 Hz 1H), 3.31 (dd, J = 12.3, 2.0 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H); 13C
NMR (125 MHz, CDCl3) δ ppm 168.9, 134.3, 132.7, 124.1, 119.3, 87.2, 84.2, 72.2, 61.8, 52.7,
51.0, 50.9, 14.1; HRMS calculated for C13H17NNaO5S (M+Na)+ 322.0725; found 322.0716.
Jeon et al. Page 12














Into a flame dried flask under argon sultam 29(862 mg, 2.88 mmol), CH3CN (11.5 mL, 0.25
M), and I2 (730 mg, 2.88 mmol) were added. The resulting solution was stirred at RT for 24
h. The reaction was quenched with aqueous NaHCO3 and the aqueous layer was extracted with
EtOAc (3 × 10 mL). The organic layer was dried (MgSO4) and was filtered. The filtrate was
concentrated under reduced pressure and purified by flash chromatography (6:1
hexane:EtOAc) to provide 78 mg (25% yield) of the desired compound. FTIR (neat): 2961,
1778, 1354, 1159, 1111 cm−1. 1H NMR (500 MHz, CDCl3) δ ppm 6.26 (dq, J = 10.1, 2.1 Hz,
1H), 5.61 (dt, J = 10.1, 2.5 Hz, 1H), 4.85 (d, J = 6.6 Hz, 1H), 4.66 (dd, J = 6.9, 3.4 Hz, 1H),
4.24 (dt, J = 19.7, 2.5 Hz, 1H), 3.99 (dd, J = 6.6, 3.5 Hz, 1H), 3.87 – 3.82 (m, 2H), 3.59 (dd,
J = 12.4, 2.1 Hz, 1H), 3.43(dd, J = 11.1, 3.5 Hz, 1H), 3.30 (dd, J = 11.1, 6.9 Hz, 1H), 3.29 (dd,
J = 12.5, 1.9 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ ppm 173.5, 132.0, 125.0, 89.4, 85.0,
81.2, 73.1, 50.9, 50.9, 49.0, 3.6. HRMS calculated for C11H12INNaO5S (M+Na)+ 419.9379;
found 419.9344.
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